Pretransplant free fatty acids (FFA) and allograft survival in renal transplantation1

Journal of Surgical Research

Volumn 164, Issue 2, 2010, Pages 182-187

  Baker, Aaron C ^a   De Mattos, Angelo ^b   Watkins, Steven ^c   German, J Bruce ^d   Troppmann, Christoph ^a   Perez, Richard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Lipomics Technologies Inc   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

arachidonic acid; eicosanoids; free fatty acids; kidney transplant; renal allograft survival; renal transplant

Indexed keywords

ARACHIDONIC ACID; FATTY ACID; GAMMA LINOLENIC ACID;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; COLD ISCHEMIA; DELAYED GRAFT FUNCTION; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; KIDNEY TRANSPLANTATION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; BIOLOGICAL MARKERS; CHILD; DELAYED GRAFT FUNCTION; FATTY ACIDS, NONESTERIFIED; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 78449284610     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.07.038     Document Type: Article

References (33)

1. C.A. Labarrere, J.B. Lee, and D.R. Nelson C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: A prospective study Lancet 360 2002 1462
2. P.M. Ridker, N. Rifai, and L. Rose Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557
3. J.T. Fitzgerald, and J.R. Johnson RV Perez. Pretransplant elevations of interleukin-12 and interleukin-10 are associated with acute rejection after renal transplantation Clin Transplant 18 2004 434
4. J.T. Fitzgerald, M.J. Sena, and K.N. Vandewalker Occult pretransplantation systemic inflammation and posttransplantation vascular changes in a primate arterial allograft model Transplantation 78 2004 367
5. R.V. Perez, D.J. Brown, and S.A. Katznelson Pretransplant systemic inflammation and acute rejection after renal transplantation Transplantation 69 2000 869
6. R.V. Perez, C.Q. Huang, and J.R. Johnson Pretransplantation soluble adhesion molecule expression predicts outcome after living donor renal transplantation Arch Surg 138 2003 1113 discussion 1119
7. J.C. Fink, M.A. Onuigbo, and S.A. Blahut Pretransplant serum C-reactive protein and the risk of chronic allograft nephropathy in renal transplant recipients: A pilot case-control study Am J Kidney Dis 39 2002 1096
8. T.M. Coffman, W.E. Yarger, and P.E. Klotman Functional role of thromboxane production by acutely rejecting renal allografts in rats J Clin Invest 75 1985 1242
9. B. Dolegowska, W. Blogowski, and L. Domanski Dynamics of thromboxane level changes during early phase of allograft reperfusion Clin Transplant 23 2009 716
10. A.J. Fabrega, J. Blanchard, and P.A. Rivas Prolongation of rat heart allograft survival using cyclosporine and enisoprost, a prostaglandin E1 analog Transplantation 53 1992 1363
11. T. Kamei, M.P. Callery, and M.W. Flye Intragraft delivery of 16, 16-dimethyl PGE2 induces donor-specific tolerance in rat cardiac allograft recipients Transplantation 51 1991 242
12. I.H. Koh, P.C. Kim, and S.W. Chung The effects of 16, 16 dimethyl prostaglandin E2 therapy alone and in combination with low-dose cyclosporine on rat small intestinal transplantation Transplantation 54 1992 592
13. M.J. Mangino, C.B. Anderson, and K. Deschryver Arachidonate lipoxygenase products and renal allograft rejection in dogs Transplantation 44 1987 805
14. M.J. Mangino, M.D. Jendrisak, and E. Brunt Eicosanoid synthesis inhibition and renal allograft function during acute rejection Transplantation 45 1988 902
15. M. Moran, M.F. Mozes, and M.S. Maddux Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone N Engl J Med 322 1990 1183
16. P. Ruiz, L. Rey, and R. Spurney Thromboxane augmentation of alloreactive T cell function Transplantation 54 1992 498
17. S.R. Smith, E.A. Creech, and V. Schaffer Effects of thromboxane synthase inhibition with CGS 13080 in human cyclosporine nephrotoxicity Kidney Int 41 1992 199
18. S.R. Smith, V.B. Kubacki, and A. Rakhit Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity Transplantation 56 1993 1422
19. R.F. Spurney, S. Ibrahim, and D. Butterly Leukotrienes in renal transplant rejection in rats. Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury J Immunol 152 1994 867
20. T.B. Strom, and C.B. Carpenter Prostaglandin as an effective antirejection therapy in rat renal allograft recipients Transplantation 35 1983 279
21. J.S. Tannenbaum, C.B. Anderson, and G.A. Sicard Prostaglandin synthesis associated with renal allograft rejection in the dog Transplantation 37 1984 438
22. P.N. Rocha, T.J. Plumb, and T.M. Coffman Eicosanoids: Lipid mediators of inflammation in transplantation Springer Semin Immunopathol 25 2003 215
23. E.M. Bulger, and R.V. Maier Lipid mediators in the pathophysiology of critical illness Crit Care Med 28 4 Suppl 2000 N27
24. M.E. Gerritsen Physiological and pathophysiological roles of eicosanoids in the microcirculation Cardiovasc Res 32 1996 720
25. M.C. Seeds, and D.A. Bass Regulation and metabolism of arachidonic acid Clin Rev Allergy Immunol 17 1999 5
26. S.L. Tilley, T.M. Coffman, and B.H. Koller Mixed messages: Modulation of inflammation and immune responses by prostaglandins and thromboxanes J Clin Invest 108 2001 15
27. L. Xie, and S.M. Innis Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation J Nutr 138 2008 2222
28. K.P. Su, S.Y. Huang, and C.Y. Peng Phospholipase A2 and Cyclooxygenase 2 Genes Influence the Risk of Interferon-alpha-Induced Depression by Regulating Polyunsaturated Fatty Acids Levels Biol Psychiatry 2009
29. C. Courivaud, J. Bamoulid, and A. Loupy Influence of cyclooxygenase-2 (COX-2) gene promoter polymorphism -765 on graft loss after renal transplantation Am J Transplant 9 2009 2752
30. J. Pene, F. Rousset, and F. Briere IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2 Proc Natl Acad Sci U S A 85 1988 6880
31. R.L. Roper, J.W. Ludlow, and R.P. Phipps Prostaglandin E2 inhibits B lymphocyte activation by a cAMP-dependent mechanism: PGE-inducible regulatory proteins Cell Immunol 154 1994 296
32. J.D. Imig Eicosanoid regulation of the renal vasculature Am J Physiol Renal Physiol 279 2000 F965
33. M.M. Polyak, B.O. Arrington, and W.T. Stubenbord Prostaglandin E1 influences pulsatile preservation characteristics and early graft function in expanded criteria donor kidneys J Surg Res 85 1999 17